Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,128 public trials 2,031 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

NCT05471843

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
View all 104 locations
View Trial Details
Active, not recruiting

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01863550

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 920 locations
View Trial Details
Active, not recruiting

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

NCT05673083

Conditions
Behavior, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Misson Cancer + Blood Des Moines, Iowa, United States
  • Hematology-Oncology Associates of Central New York East Syracuse, New York, United States
View Trial Details
Active, not recruiting

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

NCT05788081

Conditions
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV, +10 more
Locations
  • Grampians Health Ballarat, Victoria, Australia
  • Eastern Health Box Hill, Victoria, Australia
  • University Hospital Geelong, Barwon Health Geelong, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Active, not recruiting

Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae

NCT04541056

Conditions
Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Non-Hodgkin Lymphoma, +11 more
Locations
  • Oslo University Hospital - Rikshospitalet Oslo, Norway
  • St. Olavs Hospital Trondheim, Norway
  • Department of Psychology, Norwegian University of Science and Technology (NTNU) Trondheim, Norway
View Trial Details
Active, not recruiting

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

NCT03314181

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Univ of Colorado Cancer Center /ID# 167331 Aurora, Colorado, United States
  • Moffitt Cancer Center /ID# 169614 Tampa, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 165427 Atlanta, Georgia, United States
  • The University of Chicago Medical Center /ID# 165429 Chicago, Illinois, United States
View all 40 locations
View Trial Details
Active, not recruiting

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

NCT05308654

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Stanford University School of Med /ID# 242809 Stanford, California, United States
  • Sylvester Comprehensive Cancer Center /ID# 243417 Miami, Florida, United States
  • Tulane University School of Medicine /ID# 244854 New Orleans, Louisiana, United States
  • American Oncology Partners of Maryland /ID# 244858 Bethesda, Maryland, United States
View all 21 locations
View Trial Details

Related conditions